REFERENCES
- Das AK, Reddy KS, Suwanjindar P, Fulmer A, Siquiera C Jr, Floten S et
al. A. Primary Tumors of the Aorta. Ann Thorac Surg 1996;62:1526-8
- Burke A. Tumors of the heart and great vessels. Atlas of tumor
pathology 1996;16:171–9
- Yerebakan C, Liebold A, Steinhoff G, Skrabal CA. Papillary
Fibroelastoma of the Aortic Wall With Partial Occlusion of the Right
Coronary Ostium. Ann Thorac Surg 2009;87:1953–
- Rolf T, Iglesias JF, Tozzia P, von Segessera LK. Acute myocardial
infarction caused by coronary embolization of a papillary
fibroelastoma of the thoracic ascending aorta. Interactive
CardioVascular and Thoracic Surgery 11 (2010) 676–678
- Klarich KW, Enriquez-Sarano M, Gura GM, Edwards WD, Tajik AJ, Seward
JB. Papillary fibroelastoma: echocardiographic characteristics for
diagnosis and pathologic correlation. J Am Coll Cardiol
1997;30:784–90
- Anand S, Sydow N, Janardhanan R. Papillary fibroelastoma diagnosed
through multimodality cardiac imaging: a rare tumour in an uncommon
location with review of literature. BMJ Case Reports
2017(8);2017:bcr-2017-219327
- Gonzalez-Santos JM, Arnaiz-Garcıa ME, Vargas-Fajardo MC,
Arribas-Jimenez A. Aortic wall papillary fibroelastoma J Thorac
Cardiovasc Surg 2013;146:e1-3
- Sun JP, Asher CR, Yang XS, Cheng GG, Scalia GM, Massed AG et al.
Clinical and echocardiographic characteristics of papillary
fibroelastomas: a retrospective and prospective study in 162 patients.
Circulation 2001;103:2687–93.
- Gowda RM, Khan IA, Nair CK, Metha NJ, Vasadava BC Sacchi TJ. Cardiac
papillary fibroelastoma: a comprehensive analysis of 725 cases. Am
Heart J 2003;146:404–10.
Figure 1 . A: TEE showing a mobile, irregular mass of 1x1,5 cm
diameters in right coronary sinus. B: CTA scan confirming the presence
of the mass in ascending aorta
Figure 2. A: Surgical view of the mass. B: Macroscopic view of
the resected mass. C: The histology shows individual fronds consisting
of a core of hyalinized hypocellular stroma that is rich in elastic
fibers and a lining of hyperplastic endocardial cells (magnification
ratio:200:1 – 400:1. Haematoxylyn eosin staining)